Iberica USA, Inc. Launches CRO Operations In The U.S.; New Base In New York Aims To Help U.S. Biopharmas Succeed In Japan
10/19/2005 5:10:33 PM
Iberica Co., Ltd., a contract research organization headquartered in Japan, today announced the full-scale launch of its operations in the U.S. market. Using its new location in New York as a base, Iberica plans to help small- and medium-sized U.S. biopharmaceutical companies evaluate the potential for their products in Japan, conduct bridging studies to get the products approved in Japan, and provide partnering services, giving U.S. companies access to the full range of capabilities required to enable their products to succeed in the Japanese market.
comments powered by